CI Investments Inc
IONS icon

CI Investments Inc’s Ionis Pharmaceuticals IONS Stock Holding History

CI Investments Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,453
Closed -$95K – 942
2025
Q3 		$95K Sell
1,453
-963
-40% -$47K ﹤0.01% 883
2025
Q2 		$95K Sell
2,416
-126
-5% -$4.12K ﹤0.01% 916
2025
Q1 		$77K Sell
2,542
-1,548
-38% -$50.7K ﹤0.01% 977
2024
Q4 		$143K Buy
4,090
+710
+21% +$26.5K ﹤0.01% 836
2024
Q3 		$135K Sell
3,380
-272
-7% -$12.7K ﹤0.01% 765
2024
Q2 		$174K Sell
3,652
-315
-8% -$12.9K ﹤0.01% 668
2024
Q1 		$172K Sell
3,967
-1,621
-29% -$77.3K ﹤0.01% 740
2023
Q4 		$283K Buy
5,588
+3,064
+121% +$147K ﹤0.01% 546
2023
Q3 		$114K Sell
2,524
-384
-13% -$15.8K ﹤0.01% 801
2023
Q2 		$119K Buy
2,908
+1,705
+142% +$65.5K ﹤0.01% 745
2023
Q1 		$43K Buy
1,203
+1,001
+496% +$37.6K ﹤0.01% 941
2022
Q4 		$8K Buy
202
+194
+2,425% +$8.16K ﹤0.01% 1143
2022
Q3 		$0 Hold
8
– – ﹤0.01% 1288
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1326
2022
Q1 		$0 Hold
8
– – ﹤0.01% 1367
2021
Q4 		$0 Hold
8
– – ﹤0.01% 1353
2021
Q3 		$0 Buy
+8
New +$301 ﹤0.01% 1320

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CI Investments Inc's IONS Position: Q4 2025 in Review

CI Investments Inc sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 1,453 shares — an estimated $95K sold.

CI Investments Inc first reported a position in IONS in Q3 2021 and held it in 17 quarters. The position peaked at $283K in Q4 2023. 492 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • CI Investments Inc reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,453 Ionis Pharmaceuticals shares in Q4 2025, an estimated $95K.
  • CI Investments Inc first reported a position in Ionis Pharmaceuticals in Q3 2021 and held it in 17 quarters.
  • CI Investments Inc's Ionis Pharmaceuticals position peaked at $283K in Q4 2023.
  • 492 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.